Advertisement

Click here for more guidelines.

 
 




CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2009; 54:1209-1227, doi:10.1016/j.jacc.2009.07.020
© 2009 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online Appendix
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (12)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cooney, M. T.
Right arrow Articles by Graham, I. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cooney, M. T.
Right arrow Articles by Graham, I. M.
Related Collections
Right arrowRelated Article

Value and Limitations of Existing Scores for the Assessment of Cardiovascular Risk

A Review for Clinicians

Marie Therese Cooney, MB, BCh, BAO, Alexandra L. Dudina, MB and Ian M. Graham, MB, BCh, BAO, BA*

Adelaide Meath Hospital, Tallaght, Dublin, Ireland


Figure 1
View larger version (18K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 1 CHD Mortality Rates in Men <65 Years Old

Global age-standardized coronary heart disease (CHD) mortality rates in men under age 65 years (1950 to 2006). Figure drawn using World Health Organization statistics (13). Dark blue line indicates Finland; red line, France; green line, Hungary; purple line, Japan; dark red line, Ukraine; orange line, United Kingdom; light blue line, U.S.

 

Figure 2
View larger version (42K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 2 Observed to Predicted Risk

Observed to predicted risk demonstrated in external validation studies of Framingham. Reprinted from Brindle et al. (45). CHD = coronary heart disease; CI = confidence interval; CVD = cardiovascular disease; RR = relative risk; WOSCOPS = West of Scotland Coronary Prevention Study.

 

Figure 3
View larger version (58K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 3 SCORE Chart for Use in High-Risk European Regions

CVD = cardiovascular disease; SCORE = Systematic COronary Risk Evaluation.

 

Figure 4
Figure 4
View larger version (99K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 4 Formats for Some Current Risk Estimation Systems

(A) Interface for ASSIGN SCORE online calculator. (B) New Zealand risk chart (Framingham adaptation), reprinted with permission from the New Zealand Guidelines Group (18). (C) Portable Framingham risk calculator. (D) Joint British guidelines risk chart (Framingham adaptation), reprinted with permission from the British Cardiac Society et al. (48). (E) Sample WHO/ISH risk chart. (F) Interface for QRISK2 online calculator. (G) PROCAM scoring sheet. CHD = coronary heart disease; CVD = cardiovascular disease; HDL = high-density lipoprotein; LDL = low-density lipoprotein; SBP = systolic blood pressure; TC = total cholesterol; TIA = transient ischemic attack.

 

Figure 5
View larger version (30K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 5 Improved Calibration of Framingham Function in Chinese Cohort After Recalibration

Calibration, predicted event rates (open bars) compared with actual coronary heart disease (CHD) event rates (solid bars), based on (A) the original Framingham function and (B) the recalibrated Framingham function in the CMCS (Chinese Multi-Provincial Cohort Study). Reprinted from Liu et al. (58).

 

Figure 6
View larger version (34K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 6 Relative Risk Chart

This chart may be useful in explaining to a younger person that, even if his or her absolute risk is low, it may still be 10 to 12 times higher than that of a person of a similar age with low risk factors.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement